Page 23 - CIBERSAM2016-ENG

Mental Disorders of the Child
and Adolescent
Coordinator: Josefina Castro Fornieles (Hospital Clínic de Barcelona)
The programme for mental disorders of the child and adolescent set up in 2010, it is made up of six
CIBERSAM groups (G01, G04, G07, G08, G24 and G27) and has the aim of studying mental disorders with onset in childhood and adolescence.
Some of the most noteworthy outcomes of the programme’s work in 2016 are a number of 79 publications mostly in journals indexed in the first quartile according to the JCR, including the British Journal of Psychiatry, Acta Psychiatrica Scandinavica, Psychological Medicine or Human Brain Mapping. This represents a 17% increase in respect of the previous year. It should be highlighted that 19 of these works were published in first decile journals mostly in the categories of psychiatry (37%) and paediatrics (26%).
As regards the projects carried out by the members of the programme, we should mention the groups’ participation in nine European projects, including: METSY, PSYSCAN, PRECIOUS, MATRICS, AGGRESSOTYPE, PreDICT-TB or APUS-eCig, as well as obtaining regional and national financing. The Instituto de Salud Carlos III (ISCIII) issued grants for carrying out a total number of 25 projects connected with psychotic disorders with onset in childhood and adolescence, bipolar disorder, the risk of psychosis, obsessive- compulsive disorder, autism spectrum disorder, child abuse or early onset depression.
Some of the scientific achievements accomplished in 2016 are:
• The clinical, neuropsychological, neuroimaging and genetic characterisation of children and adolescents with a high genetic risk of schizophrenia or bipolar disorder.
• The study of the role of genetic and epigenetic variants in the clinical improvement of children treated with fluoxetine.
• The creation of a predictive model of the severity of obsessive-compulsive disorder based on genetic, cognitive and neuroimaging variables.
• Study on the role of cognitive variables in high-functioning autism.
• The study of the effects of anti-psychotic medication in weight gain and hormones in children and adolescents, as well as the study of the extrapyramidal symptoms which these could cause.
• The development and validation of specific scales for the child and juvenile population valuing obsessive-compulsive symptomatology and the risk of suicide.
• The study of pharmacogenetics of methylphenidate in treatment of Attention Deficit Disorder.
• The study of the role of the childhood trauma in different psychiatric pathologies.
SAM
Scientific Programmes 23